Blood Component Transfusions for Infants

Rossi's Principles of Transfusion Medicine: Fourth Edition

Volumn , Issue , 2009, Pages 470-481

  Strauss, Ronald G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84991491437     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303513.ch30     Document Type: Chapter

References (64)

1. Strauss RG. Current issues in neonatal transfusions. Vox Sang 1996;51:1-9.
2. Stockman JA. Anemia of prematurity: Current concepts in the issue of when to transfuse. Pediatr Clin North Am 1986;33:111-28.
3. Widness JA, Madan A, Grindeanu LA, et al. Reduction in red blood cell transfusions among preterm infants: Results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 2005;115:1299-306.
4. Madan A, Kumar R, Adams MM, et al. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 2005;25:2-25.
5. Stockman III JA, Graeber JE, Clark DA, et al. Anemia of prematurity: Determinants of the erythropoietin response. J Pediatr 1984;105:786-92.
6. Brown MS, Garcia JF, Phibbs RH, et al. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr 1984;105:793-8.
7. Rhondeau SM, Christensen RD, Ross MP, et al. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with "anemia of prematurity." J Pediatr 1988;112:935-40.
8. Dame C, Fahnenstich H, Freitag P, et al. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 1998;92:3218-25.
9. Snijders RJ, Abbas A, Melby O, et al. Fetal plasma erythropoietin concentration in severe growth retardation. Am J Obstet Gynecol 1993;168:615-19.
10. Widness JA, Susa JB, Garcia JF, et al. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest 1981;67:637-42.
11. Ohls RK, Li Y, Trautman MS, Christensen RD. Erythropoietin production by macrophages from preterm infants: Implications regarding the cause of the anemia in prematurity. Pediatr Res 1994;35:169-70.
12. Widness JA, Veng-Pedersen P, Peters C, et al. Erythropoietin pharmacokinetics in premature infants: Developmental, nonlinearity, and treatment effects. J Appl Physiol 1996;80:140-8.
13. Strauss RG. Managing the anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin. Transfus Med Rev 2001;15:213-23.
14. Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusions in preterm infants. Pediatrics 2005;115:1685-91.
15. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: A randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006;149:301-7.
16. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995:22:641-55.
17. Ramasethu J, Luban NL. Red blood cell transfusions in the newborn. Semin Neonatol 1999:4:5-16.
18. Stockman JA, Clark DA. Weight gain: A response to transfusion in selected preterm infants. Am J Dis Child 1984;138:828-35.
19. Phillips HM, Holland BM, Abdel-Moiz A, et al. Determination of red-cell mass in assessment and management of anaemia in babies needing blood transfusion. Lancet 1986;i:882-4.
20. Jones JG, Holland BM, Veale KE, Wardrop CA. "Available oxygen," a realistic expression of the ability of the blood to supply oxygen to tissues. Scand J Haematol 1979;22:77-82.
21. Alverson DC, Isken VH, Cohen RS. Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia. J Pediatr 1988;113:722-6.
22. Strauss RG, Mock DM, Johnson K, et al. Circulating red blood cell (RBC) volume, measured using biotinylated RBCs, is superior to the hematocrit to document the hematologic effects of delayed versus immediate umbilical cord clamping in preterm neonates. Transfusion 2003;43:1168-72.
23. Strauss RG, Villhauer PJ, Cordle DG. A method to collect, store and issue multiple aliquots of packed red blood cells for neonatal transfusions. Vox Sang 1995;68:77-81.
24. Luban NLC, Strauss RG, Hume HA. Commentary on the safety of red blood cells preserved in extended storage media for neonatal transfusions. Transfusion 1991;31:229-35.
25. Strauss RG. Data-driven blood banking practices for neonatal RBC transfusions. Transfusion 2000;40:1528-40.
26. Strauss RG, Burmeister LF, Johnson K, et al. AS-1 red blood cells for neonatal transfusions: A randomized trial assessing donor exposure and safety. Transfusion 1996;36:873-8.
27. Strauss RG, Burmeister LF, Johnson K, et al. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000;136:215-19.
28. Strauss RG, Burmeister LF, Johnson K, et al. Randomized trial assessing feasibility and safety of biological parents as red blood cell donors for their preterm infants. Transfusion 2000;40:450-6.
29. Walsh TS, McArdle F, McLellan SA, et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004;32:364-71.
30. Weiskopf RB, Feiner J, Hopf H, et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia- induced brain oxygenation deficits in humans. Anesthesiology 2006;104:911-20.
31. Strauss RG, Mock DM, Widness JA, et al. Post-transfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion 2004;44:871-6.
32. Hilsenrath P, Nemechek J, Widness JA, et al. Cost-effectiveness of a limited donor blood program for neonatal RBC transfusions. Transfusion 1999;39:938-43.
33. Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of recombinant human erythropoietin in reducing blood transfusions in the anemia of prematurity. Transfusion 2001;41:406-15.
34. Donato H, Vain N, Rendo P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000;105:1066-72.
35. Yeo CL, Choo S, Ho LY. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. J Paediatr Child Health 2001;37:352-8.
36. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fetal Neonatal Ed 2003;88:F41-F45.
37. Maier RE, Obladen M, Müller-Hansen I, et al on behalf of the European Multicenter Erythropoietin Beta Study Group. Early treatment with erythropoietin ß ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002;141:8-15.
38. Avent M, Cory BJ, Galpin J, et al. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anemia of prematurity in a developing country. J Trop Pediatr 2002;48:227-33.
39. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed 2001;84:F96-F100.
40. Amin AA, Alzahrani DM. Efficacy of erythropoietin in premature infants. Saudi Med J 2002;23:287-90.
41. Anderson A, Fangman J, Wager G, Uden D. Retrieval of placental blood from the umbilical vein to determine volume, sterility, and presence of clot formation. Am J Dis Child 1992;146:36-9.
42. Bifano EM, Dracker RA, Lorah K, Palit A. Collection and 28-day storage of human placental blood. Pediatr Res 1994;36:90-4.
43. Strauss RG. Autologous transfusions for neonates using placental blood. A cautionary note. Am J Dis Child 1992;146:21-2.
44. Mercer JS, Vohr BR, McGrath MM, et al. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: A randomized, controlled trial. Pediatrics 2006;117:1235-42.
45. Castle V, Andrew M, Kelton J, et al. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986:108:749-55.
46. Castro V, Kroll H, Origa AF, et al. A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns. Transfusion 2007;47:59-66.
47. Andrew M, Castle V, Saigal S, et al. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987;110:457-64.
48. 111In-oxine platelet survivals in thrombocytopenic infants. Blood 1987;70:652-6.
49. Sola-Visner MC, Christensen RD, Hutson AD, Rimsza LM. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res 2007;61:479-84.
50. Murray NA, Roberts IA. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 1996;40:112-19.
51. Sola MC, Calhoun DA, Hutson AD, Christensen RD. Plasma throm- bopoietin concentrations in thrombocytopenic and nonthrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999;104:90-2.
52. Pastos KM, Slayton W, Rimsza LM, et al. Differential effects of recombinant thrombopoietin and bone marrow stromal conditioned media on neonatal vs adult megakaryocytes. Blood 2006;108:3360-2.
53. Andrew M, Vegh P, Caco C, et al. A randomized trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993;123:285-91.
54. Lupton BA, Hill A, Whitfield MF, et al. Reduced platelet count as a risk factor for intraventricular hemorrhage. Am J Dis Child 1988;142:1222-4.
55. Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-8.
56. Mathew P, Young G. Recombinant factor VIIa in paediatric bleeding disorders-a 2006 review. Haemophilia 2006;12:457-72.
57. Rosenthal J, Cairo MS. Neonatal myelopoiesis and immunomodu- lation of host defenses. In: Petz LD, Swisher SN, Kleinman S, et al, eds. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1995:685-704.
58. Christensen RD, MacFarlane JL, Taylor NL, et al. Blood and marrow neutrophils during experimental group B streptococcal infection: Quantification of the stem cell, proliferative, storage and circulating pools. Pediatr Res 1982;16:549-54.
59. Erdman SH, Christensen RD, Bradley PP, Rothstein G. Supply and release of storage neutrophils: A developmental study. Biol Neonate 1982;41:132-7.
60. Strauss RG. Current status of granulocyte transfusions to treat neonatal sepsis. J Clin Apher 1989;5:25-9.
61. Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997;99:E2.
62. Schibler KR, Osborne KA, Leung LY, et al. A randomized, placebocontrolled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998;102:6-13.
63. Cairo MS, Agosti J, Ellis R, et al. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 1999;134:64-70.
64. Calhoun DA, Lunoe M, Du Y, et al. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor. Pediatrics 2000;105:392-7.